Regen BioPharma Inc Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regen BioPharma Inc quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Regen BioPharma Inc Return On Assets for the quarter ending June 30, 2024 was -450 %, a 234% decline year-over-year.
  • Regen BioPharma Inc annual Return On Assets for 2023 was 317 %, a 15.2% decline from 2022.
  • Regen BioPharma Inc annual Return On Assets for 2022 was 374 %.
  • Regen BioPharma Inc annual Return On Assets for 2021 was -910 %, a 124% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 317 -56.9 -15.2% Oct 1, 2022 Sep 30, 2023
2022 374 +1.28K Oct 1, 2021 Sep 30, 2022
2021 -910 -4.76K -124% Oct 1, 2020 Sep 30, 2021
2020 3.85K +6.23K Oct 1, 2019 Sep 30, 2020
2019 -2.39K -1.68K -238% Oct 1, 2018 Sep 30, 2019
2018 -705 +21.2 +2.92% Oct 1, 2017 Sep 30, 2018
2017 -726 +2.14K +74.7% Oct 1, 2016 Sep 30, 2017
2016 -2.87K +1.41K +32.9% Oct 1, 2015 Sep 30, 2016
2015 -4.27K Oct 1, 2014 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.